Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country.

Saved in:
Bibliographic Details
Title: Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country.
Authors: Baş O; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Sert L; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye., Balçık OY; Division of Medical Oncology, Mardin State Hospital, Mardin, Türkiye., Tokatli M; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Boyraz NE; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Kavgaci G; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Şahin TK; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Güven DC; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Arık Z; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Işikdoğan A; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye., Erman M; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2025 Oct; Vol. 25 (10), pp. 1213-1219. Date of Electronic Publication: 2025 Jul 06.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-8328
DOI:10.1080/14737140.2025.2529290